| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |